DOCSLIB.ORG

Modes of Delivery in Concurrent Nicotine and Cannabis Use (“Co-Use”) Among Youth: Findings from the International Tobacco Control (ITC) Survey

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Modes of Delivery in Concurrent Nicotine and Cannabis Use (“Co-Use”) Among Youth: Findings from the International Tobacco Control (ITC) Survey Substance Abuse ISSN: 0889-7077 (Print) 1547-0164 (Online) Journal homepage: https://www.tandfonline.com/loi/wsub20 Modes of delivery in concurrent nicotine and cannabis use (“co-use”) among youth: Findings from the International Tobacco Control (ITC) Survey Danielle M. Smith, Connor Miller, Richard J. O’Connor, Lynn T. Kozlowski, Elle Wadsworth, Brian V. Fix, R. Lorraine Collins, Binnian Wei, Maciej L. Goniewicz, Andrew J. Hyland & David Hammond To cite this article: Danielle M. Smith, Connor Miller, Richard J. O’Connor, Lynn T. Kozlowski, Elle Wadsworth, Brian V. Fix, R. Lorraine Collins, Binnian Wei, Maciej L. Goniewicz, Andrew J. Hyland & David Hammond (2020): Modes of delivery in concurrent nicotine and cannabis use (“co-use”) among youth: Findings from the International Tobacco Control (ITC) Survey, Substance Abuse, DOI: 10.1080/08897077.2019.1709603 To link to this article: https://doi.org/10.1080/08897077.2019.1709603 Published online: 17 Jan 2020. Submit your article to this journal Article views: 10 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=wsub20 SUBSTANCE ABUSE https://doi.org/10.1080/08897077.2019.1709603 ORIGINAL RESEARCH Modes of delivery in concurrent nicotine and cannabis use (“co-use”) among youth: Findings from the International Tobacco Control (ITC) Survey Danielle M. Smith, MPHa,b, Connor Miller, MSa, Richard J. O’Connor, PhDa, Lynn T. Kozlowski, PhDb, Elle Wadsworth, MScc , Brian V. Fix, MAa, R. Lorraine Collins, PhDb, Binnian Wei, PhDa, Maciej L. Goniewicz, PhDa, Andrew J. Hyland, PhDa, and David Hammond, PhDc aDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA; bDepartment of Community Health and Health Behavior, University at Buffalo, Buffalo, New York, USA; cSchool of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada ABSTRACT KEYWORDS Background: Cannabis use is more common among nicotine users than non-users. This study char- Cannabis; nicotine; youth; acterized concurrent use of nicotine and cannabis (“co-use”) among 12,064 youth aged 16–19 years vaping; co-use; modes residing in Canada, the United States, and England in 2017. Methods: Data were from the ITC of delivery Youth Tobacco & Vaping Survey (Wave 1). Seven modes of cannabis delivery (MOD) were charac- terized by country of residence and past 30-day use of combusted tobacco and electronic ciga- rettes. Weighted multivariable regression models were fitted to assess the correlates of co-use and each cannabis MOD. Results: Seventy percent of cannabis users reported nicotine use. Co-users exhibited behavioral and demographic differences compared to exclusive users of either sub- stance. “Smoking cannabis without tobacco” was the most popular form of use (78%). Use of nico- tine-containing e-cigarettes was associated with “using an e-cigarette to vape cannabis oil/liquid” (aOR: 4.96, 95%CI: 2.23–11.06). Combustible tobacco use was associated with “smoking cannabis with tobacco in a joint/blunt” (aOR: 2.93, 95%CI: 1.89–4.56). Country-level differences were detected. Conclusions: Nicotine use is substantial among cannabis users, and associations exist between modes of delivery for both drugs. Results underscore the importance of studying canna- bis and nicotine use concurrently, and the need to address the use of both substances in develop- ing interventions for youth users. Introduction cannabis use, and 3.9% reporting exclusive nicotine use.8 Prior research suggests there are a number of problems Use of cannabis and nicotine among youth presents a sub- related to co-use, including heavier nicotine and cannabis stantial global public health burden, with an estimated 13.8 use, greater dependence on both substances, difficulty in – million youth aged 15 16 years reporting past-year use of quitting cannabis use, linkage to problematic use of alcohol cannabis in 2016, and 25 million youth reporting current 1 and other illicit drugs, increased likelihood of experiencing use of cigarettes or smokeless tobacco. Youth commonly psychotic symptoms later in life, and elevated exposure risks – experiment with these substances, which may present ele- for smoke-related toxicants.9 13 Commonalities in the pri- vated health harms related to brain development and risks mary route of administration for both substances (i.e., 2,3 of developing substance use disorders. In many high- inhalation) have been posited as reinforcing mechanisms of income countries, rates of youth cigarette smoking are co-use, which may serve to further compound-related health declining, while youth trial and use of electronic cigarettes harms.14 The significant overlap between the modes of deliv- (“e-cigarettes”) and electronic vapor products is increas- ery used to administer cannabis and nicotine may also con- – ing.4 6 In tandem, changes in cannabis policies have contrib- tribute to emerging co-use patterns. Many tobacco products uted to considerable expansion of the cannabis market in can be used for cannabis administration (i.e., flavored rolling recent years, with a greater diversity of products and modes papers, blunts),15,16 and vaporized modes of delivery are of delivery in both “illegal” and “legal” markets.7 available for both substances.17,18 The use of cannabis and nicotine are often studied in iso- Cross-national differences in cannabis and nicotine lation with respect to the other substance. However, concur- modes of delivery exist, yet often remain unexamined rent use (“co-use”) of cannabis and nicotine is common, through the lens of co-use. Smoking remains the predomin- with estimates showing 5.4% of youth reporting co-use in ant form of cannabis delivery, but specific practices related the United States, compared with 2.2% reporting exclusive to cannabis smoking are regionally and culturally CONTACT Danielle M. Smith, MPH [email protected] Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY 14263, USA. ß 2020 Taylor & Francis Group, LLC 2 D. M. SMITH ET AL. determined.19 For example, mixing cannabis and tobacco in the survey was kept anonymous and used exclusively in “spliffs”/“mulled cigarettes” (i.e., joints that mix tobacco aggregate form during analyses.29 with cannabis) or “blunts” (i.e., cigars that have been hol- lowed out and filled with cannabis) are common co-admin- Measures istration practices, with spliff use being far more common in Western European countries, and blunt use occurring more Cannabis use and modes of delivery 19–21 frequently in North American countries. Further, coun- Cannabis use was assessed using the following question: tries with a different regulatory treatment of e-cigarettes and “When was the last time you used marijuana/cannabis?” vaping products display differences in public perceptions of (response options: “I have never used cannabis;”“Earlier 22 these products, and their subsequent adoption and use. today;”“Not today but sometime in the past week;”“Not in For example, in England, authorities place substantial the past week but sometime in the past month;”“Not in the restrictions on e-cigarette advertising, promotion, and allow- past month but sometime in the past 6 months;”“Not in the able nicotine content in the products, which have been past 6 months but sometime in the past year;”“1 to 4 years largely normalized for the purpose of tobacco smoking ces- ago;”“5 or more years ago”). Participants who responded 23 sation. A recent cross-national study showed that past 30- “earlier today”; “not today but sometime in the past week”; day nicotine vaping was less common among youth in or “not in the past week but sometime in the past month” England compared to youth in the United States and 24 were classified as past 30-day cannabis users. Past 30-day Canada. Cultural contexts specific to nicotine products cannabis users were asked to report on their use of seven could influence cannabis use behaviors and vice versa. different modes of delivery: “In the last 30 days, did you … :” Characterizations of co-use in light of diversifying modes (a) “smoke cannabis without tobacco;” (b) “smoke cannabis of delivery remain sparse,25,26 and have not been examined with tobacco in a joint or blunt;” (c) “use a waterpipe or in a cross-national context. The primary objective of this bong to smoke cannabis;” (d) “use a vaporizer to heat dried study was to characterize cannabis and nicotine co-use pat- cannabis leaves or herb;” (e) “use an e-cigarette to vape can- terns among youth aged 16–19 years in three countries, nabis oil or liquid;” (f) “eat or drink cannabis in a food or based on their past-30 day use of different modes of canna- beverage;” (g) “use cannabis extracts, including oil, wax or bis and nicotine delivery. Secondary objectives aimed to shatter” (response options for each: Yes, No). assess correlates of co-use and specific cannabis modes of delivery. Nicotine use and modes of delivery “ Methods All respondents answered the following questions: Have you ever tried a cigarette, even one or two puffs?”; “Have Data source you ever tried an e-cigarette, even one or two puffs?” Participants who responded “Yes” were successively asked: Data are from Wave 1 of the International Tobacco Control “When was the last time you used a … [cigarette/e-ciga- Policy Evaluation Youth Tobacco and Vaping Survey, con- ” ducted in July/August 2017 among 12,064 youth aged rette]? Youth selected from the following answers: (a) “ ” “ 16–19 years, in Canada (CA; n ¼ 4008), England (EN; Earlier today; (b) Not today but sometime in the past ” “ n ¼ 3970), and the United States (US; n ¼ 4086). Participants 7 days; (c) Not in the past 7 days but sometime in the past ” “ were recruited through Nielsen’s Consumer Insights Global 30 days; (d) Not in the past 30 days but sometime in the ” “ Panel and affiliated partners using a blend of probability past 6 months; (e) Not in the past 6 months but sometime ” “ ” “ and non-probability-based sampling strategies.
Load more

Recommended publications
  • Smoking Cessation Treatment at Substance Abuse Rehabilitation Programs
    SMOKING CEssATION TREATMENT AT SUBSTANCE ABUSE REHABILITATION PROGRAMS Malcolm S. Reid, PhD, New York University School of Medicine, Department of Psychiatry; Jeff Sel- zer, MD, North Shore Long Island Jewish Healthcare System; John Rotrosen, MD, New York University School of Medicine, Department of Psychiatry Cigarette smoking is common among persons with drug and alcohol n Nicotine is a highly use disorders, with prevalence rates of 80-90% among patients in sub- addictive substance stance use disorder treatment programs. Such concurrent smoking may that meets all of produce adverse behavioral and medical problems, and is associated the criteria for drug with greater levels of substance use disorder. dependence. CBehavioral studies indicate that the act of cigarette smoking serves as a cue for drug and alcohol craving, and the active ingredient of cigarettes, nicotine, serves as a primer for drug and alcohol abuse (Sees and Clarke, 1993; Reid et al., 1998). More critically, longitudinal studies have found tobacco use to be the number one cause of preventable death in the United States, and also the single highest contributor to mortality in patients treated for alcoholism (Hurt et al., 1996). Nicotine is a highly addictive substance that meets all of the criteria for drug dependence, and cigarette smoking is an especially effective method for the delivery of nicotine, producing peak brain levels within 15-20 seconds. This rapid drug delivery is one of a number of common properties that cigarette smok- ing shares with hazardous drug and alcohol use, such as the ability to activate the dopamine system in the reward circuitry of the brain.
    [Show full text]
  • Alcohol, Tobacco, and Prescription Drugs: the Relationship with Illicit Drugs in the Treatment of Substance Users
    Macquarie University ResearchOnline This is the author version of an article published as: Teesson, M., Farrugia, P., Mills, K., Hall, W., & Baillie, A. (2012). Alcohol, tobacco, and prescription drugs: The relationship with illicit drugs in the treatment of substance users. Substance use & misuse, Vol. 47, Issue 8-9, p. 963-971. Access to the published version: http://doi.org/10.3109/10826084.2012.663283 Copyright: Copyright the Publisher 2012. Version archived for private and non- commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher. Comorbidity 1 Alcohol, tobacco and prescription drugs: The relationship with illicit drugs in the treatment of substance users. Maree Teesson, Philippa Farrugia, Katherine Mills 1 Wayne Hall2, Andrew Baillie3. 1. National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales 2052 Australia, 2. University of Queensland Centre for Clinical Research, 3. Centre for Emotional Health, Department of Psychology, Macquarie University. * Corresponding author: Maree Teesson National Drug and Alcohol Research Centre University of New South Wales, Sydney New South Wales 2052 Australia Tel: +61 2 9385 0333; fax: +61 2 9385 0222; email: [email protected] Abstract Alcohol, tobacco, prescription drug and illicit drug use frequently co-occur. This paper reviews the extent of this co-occurrence in both general population samples and clinical samples, and its impact on treatment outcome. We argue that the research base for understanding comorbidity between tobacco, alcohol, prescription and illicit drugs needs to be broadened. We specifically advocate for: 1) more epidemiological studies of relationships between alcohol, tobacco and other illicit drug use; and 2) increased research on treatment options that address the problematic use of all of these drugs.
    [Show full text]
  • Concurrent Alcohol and Tobacco Dependence
    Concurrent Alcohol and Tobacco Dependence Mechanisms and Treatment David J. Drobes, Ph.D. People who drink alcohol often also smoke and vice versa. Several mechanisms may contribute to concurrent alcohol and tobacco use. These mechanisms include genes that are involved in regulating certain brain chemical systems; neurobiological mechanisms, such as cross-tolerance and cross-sensitization to both drugs; conditioning mechanisms, in which cravings for alcohol or nicotine are elicited by certain environmental cues; and psychosocial factors (e.g., personality characteristics and coexisting psychiatric disorders). Treatment outcomes for patients addicted to both alcohol and nicotine are generally worse than for people addicted to only one drug, and many treatment providers do not promote smoking cessation during alcoholism treatment. Recent findings suggest, however, that concurrent treatment for both addictions may improve treatment outcomes. KEY WORDS: comorbidity; AODD (alcohol and other drug dependence); alcoholic beverage; tobacco in any form; nicotine; smoking; genetic linkage; cross-tolerance; AOD (alcohol and other drug) sensitivity; neurotransmitters; brain reward pathway; cue reactivity; social AODU (AOD use); cessation of AODU; treatment outcome; combined modality therapy; literature review lcohol consumption and tobacco ers who are dependent on nicotine Department of Health and Human use are closely linked behaviors. have a 2.7 times greater risk of becoming Services 1989). The concurrent use of A Thus, not only are people who alcohol dependent than nonsmokers both drugs by pregnant women can drink alcohol more likely to smoke (and (e.g., Breslau 1995). Finally, although also result in more severe prenatal dam- vice versa) but also people who drink the smoking rate in the general popula­ age and neurocognitive deficits in their larger amounts of alcohol tend to smoke tion has gradually declined over the offspring than use of either drug alone more cigarettes.
    [Show full text]
  • Cannabis (Sub)Culture, the Subcultural Repository, and Networked Mediation
    SIMULATED SESSIONS: CANNABIS (SUB)CULTURE, THE SUBCULTURAL REPOSITORY, AND NETWORKED MEDIATION Nathan J. Micinski A Thesis Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF ARTS May 2014 Committee: Ellen Berry, Advisor Rob Sloane © 2014 Nathan Micinski All Rights Reserved iii ABSTRACT Ellen Berry, Advisor Subcultural theory is traditionally rooted in notions of social deviance or resistance. The criteria for determining who or what qualifies as subcultures, and the most effective ways to study them, are based on these assumptions. This project seeks to address these traditional modes of studying subcultures and discover ways in which their modification may lead to new understandings and ways of studying subcultures in the contemporary moment. This will be done by suggesting a change in the criteria of examining subcultures from that of deviance or resistance to identification with a collection of images, symbols, rituals, and narratives. The importance of this distinction is the ability to utilize the insights that studying subcultures can offer while avoiding the faults inherent in speaking for or at a subculture rather than with or from it. Beyond addressing theoretical concerns, this thesis aims to apply notions of subcultural theory to study the online community of Reddit, in particular, a subset known as r/trees–a virtual repository for those images, symbols, rituals, and narratives of cannabis subculture. R/trees illustrates the life and vibrancy of a unique subcultural entity, which to this point has evaded a cultural studies analysis. To that end, this project advocates for the importance of the cultural studies approach to analyzing cannabis subculture and further, to insert the findings of this study into that gap in the literature.
    [Show full text]
  • Nicotine and Methylphenidate Chornic Exposure on Adult Cannabinoid Receptor Agonist (Cp 55,940) Place Conditioning in Male Rats
    California State University, San Bernardino CSUSB ScholarWorks Electronic Theses, Projects, and Dissertations Office of aduateGr Studies 6-2016 NICOTINE AND METHYLPHENIDATE CHORNIC EXPOSURE ON ADULT CANNABINOID RECEPTOR AGONIST (CP 55,940) PLACE CONDITIONING IN MALE RATS Christopher P. Plant California State University - San Bernardino Follow this and additional works at: https://scholarworks.lib.csusb.edu/etd Part of the Biological Psychology Commons, and the Clinical Psychology Commons Recommended Citation Plant, Christopher P., "NICOTINE AND METHYLPHENIDATE CHORNIC EXPOSURE ON ADULT CANNABINOID RECEPTOR AGONIST (CP 55,940) PLACE CONDITIONING IN MALE RATS" (2016). Electronic Theses, Projects, and Dissertations. 339. https://scholarworks.lib.csusb.edu/etd/339 This Thesis is brought to you for free and open access by the Office of aduateGr Studies at CSUSB ScholarWorks. It has been accepted for inclusion in Electronic Theses, Projects, and Dissertations by an authorized administrator of CSUSB ScholarWorks. For more information, please contact [email protected]. NICOTINE AND METHYLPHENIDATE CHRONIC EXPOSURE ON ADULT CANNABINOID RECEPTOR AGONIST (CP 55,940) PLACE CONDITIONING IN MALE RATS A Thesis Presented to the Faculty of California State University, San Bernardino In Partial Fulfillment of the Requirements for the Degree Master of Arts in General-Experimental Psychology by Christopher Philip Plant June 2016 NICOTINE AND METHYLPHENIDATE CHRONIC EXPOSURE ON ADULT CANNABINOID RECEPTOR AGONIST (CP 55,940) PLACE CONDITIONING IN MALE
    [Show full text]
  • Barriers and Solutions to Addressing Tobacco Dependence in Addiction Treatment Programs
    Barriers and Solutions to Addressing Tobacco Dependence in Addiction Treatment Programs Douglas M. Ziedonis, M.D., M.P.H.; Joseph Guydish, Ph.D., M.P.H.; Jill Williams, M.D.; Marc Steinberg, Ph.D.; and Jonathan Foulds, Ph.D. Despite the high prevalence of tobacco use among people with substance use disorders, tobacco dependence is often overlooked in addiction treatment programs. Several studies and a meta-analytic review have concluded that patients who receive tobacco dependence treatment during addiction treatment have better overall substance abuse treatment outcomes compared with those who do not. Barriers that contribute to the lack of attention given to this important problem include staff attitudes about and use of tobacco, lack of adequate staff training to address tobacco use, unfounded fears among treatment staff and administration regarding tobacco policies, and limited tobacco dependence treatment resources. Specific clinical-, program-, and system-level changes are recommended to fully address the problem of tobacco use among alcohol and other drug abuse patients. KEY WORDS: Alcohol and tobacco; alcohol, tobacco, and other drug (ATOD) use, abuse, dependence; addiction care; tobacco dependence; smoking; secondhand smoke; nicotine; nicotine replacement; tobacco dependence screening; tobacco dependence treatment; treatment facility-based prevention; co-treatment; treatment issues; treatment barriers; treatment provider characteristics; treatment staff; staff training; AODD counselor; client counselor interaction; smoking cessation; Tobacco Dependence Program at the University of Medicine and Dentistry of New Jersey obacco dependence is one of to the other. The common genetic vul­ stance use was considered a potential the most common substance use nerability may be located on chromo­ trigger for the primary addiction.
    [Show full text]
  • Model Ordinance Prohibiting Smoking in All Workplaces and Public Places (100% Smokefree)
    Model Ordinance Prohibiting Smoking in All Workplaces and Public Places (100% Smokefree) Sec. 1000. Title This Article shall be known as the _______________ [name of City or County] Smokefree Air Ordinance of ______ [year]. Sec. 1001. Findings and Intent The _______________ [City or County Governing Body] does hereby find that: The 2006 U.S. Surgeon General's Report, The Health Consequences of Involuntary Exposure to Tobacco Smoke, has concluded that (1) secondhand smoke exposure causes disease and premature death in children and adults who do not smoke; (2) children exposed to secondhand smoke are at an increased risk for sudden infant death syndrome (SIDS), acute respiratory problems, ear infections, and asthma attacks, and that smoking by parents causes respiratory symptoms and slows lung growth in their children; (3) exposure of adults to secondhand smoke has immediate adverse effects on the cardiovascular system and causes coronary heart disease and lung cancer; (4) there is no risk-free level of exposure to secondhand smoke; (5) establishing smokefree workplaces is the only effective way to ensure that secondhand smoke exposure does not occur in the workplace, because ventilation and other air cleaning technologies cannot completely control for exposure of nonsmokers to secondhand smoke; and (6) evidence from peer-reviewed studies shows that smokefree policies and laws do not have an adverse economic impact on the hospitality industry.1 According to the 2010 U.S. Surgeon General's Report, How Tobacco Smoke Causes Disease, even occasional exposure to secondhand smoke is harmful and low levels of exposure to secondhand tobacco smoke lead to a rapid and sharp increase in dysfunction and inflammation of the lining of the blood vessels, which are implicated in heart attacks and stroke.2 According to the 2014 U.S.
    [Show full text]
  • Marijuana Myths and Facts: the Truth Behind 10 Popular Misperceptions
    MARIJUANA myths & FACTS The Truth Behind 10 Popular Misperceptions OFFICE OF NATIONAL DRUG CONTROL POLICY MARIJUANA myths & FACTS The Truth Behind 10 Popular Misperceptions OFFICE OF NATIONAL DRUG CONTROL POLICY TABLE OF CONTENTS Introduction.............................................................................. 1 Myth #1: Marijuana is harmless .......................................... 3 Myth #2: Marijuana is not addictive ................................... 7 Myth #3: Marijuana is not as harmful to your health as tobacco............................................................. 9 Myth #4: Marijuana makes you mellow............................. 10 Myth #5: Marijuana is used to treat cancer and other diseases...................................................... 11 Myth #6: Marijuana is not as popular as MDMA (Ecstasy) or other drugs among teens today...................... 13 Myth #7: If I buy marijuana, I’m not hurting anyone else......................................................... 14 Myth #8: My kids won’t be exposed to marijuana ............. 17 Myth #9: There’s not much parents can do to stop their kids from experimenting with marijuana ........... 19 Myth #10: The government sends otherwise innocent people to prison for casual marijuana use......... 21 Conclusion .............................................................................. 23 Glossary.................................................................................. 25 References ..............................................................................
    [Show full text]
  • Evidence-Based Guidelines for the Pharmacological Management of Substance Abuse, Harmful Use, Addictio
    444324 JOP0010.1177/0269881112444324Lingford-Hughes et al.Journal of Psychopharmacology 2012 BAP Guidelines BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, Journal of Psychopharmacology 0(0) 1 –54 harmful use, addiction and comorbidity: © The Author(s) 2012 Reprints and permission: sagepub.co.uk/journalsPermissions.nav recommendations from BAP DOI: 10.1177/0269881112444324 jop.sagepub.com AR Lingford-Hughes1, S Welch2, L Peters3 and DJ Nutt 1 With expert reviewers (in alphabetical order): Ball D, Buntwal N, Chick J, Crome I, Daly C, Dar K, Day E, Duka T, Finch E, Law F, Marshall EJ, Munafo M, Myles J, Porter S, Raistrick D, Reed LJ, Reid A, Sell L, Sinclair J, Tyrer P, West R, Williams T, Winstock A Abstract The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of these disorders, reviewed key areas and considered the strength of the evidence and clinical implications. The guidelines were drawn up after feedback from participants. The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people. Keywords Substance misuse, addiction, guidelines, pharmacotherapy, comorbidity Introduction guidelines (e.g.
    [Show full text]
  • Use of Non Cigarette Tobacco Products (NCTP) Smokeless
    Non Cigarette Tobacco Products (NCTP) and Electronic cigarettes (e-cigs) Michael V. Burke EdD Asst: Professor of Medicine Nicotine Dependence Center Mayo Clinic, Rochester, MN Email: [email protected] ©2011 MFMER | slide-1 Goals & Objectives • Review NCTP definitions & products • Discuss prevalence/trends of NCTP • Discuss NCTP and addiction • Review recommended treatments for NCTP ©2011 MFMER | slide-2 NCTP Definitions & Products ©2011 MFMER | slide-3 Pipes ©2011 MFMER | slide-4 Cigars Images from www.trinketsandtrash.org ©2011 MFMER | slide-5 Cigar Definition U.S. Department of Treasury (1996): Cigar “Any roll of tobacco wrapped in leaf tobacco or any substance containing tobacco.” vs. Cigarette “Any roll of tobacco wrapped in paper or in any substance not containing tobacco.” ©2011 MFMER | slide-6 NCI Monograph 9. Cigars: Health Effects and Trends. ©2011 MFMER | slide-7 ©2011 MFMER | slide-8 Smokeless Tobacco Chewing tobacco • Loose leaf (i.e., Redman) • Plugs • Twists Snuff • Moist (i.e., Copenhagen, Skoal) • Dry (i.e., Honest, Honey bee, Navy, Square) ©2011 MFMER | slide-9 “Chewing Tobacco” = Cut tobacco leaves ©2011 MFMER | slide-10 “Snuff” = Moist ground tobacco ©2011 MFMER | slide-11 Type of ST Used in U.S. Chewing Tobacco Snuff National Survey on Drug Use and Health (NSDUH) ©2011 MFMER | slide-12 “Spitless Tobacco” – Star Scientific ©2011 MFMER | slide-13 RJ Reynold’s ©2011 MFMER | slide-14 “Swedish Style” ST ©2011 MFMER | slide-15 Phillip Morris (Altria) ©2011 MFMER | slide-16 New Product: “Fully Dissolvables” ©2011 MFMER
    [Show full text]
  • Cannabis Ordinance Revisions; Amending Berkeley Municipal Code Chapters 12.21, 12.22, 20.40, 23C.25, and Sub-Titles 23E and 23F
    Page 1 of 99 Office of the City Manager PUBLIC HEARING January 28, 2020 To: Honorable Mayor and Members of the City Council From: Dee Williams-Ridley, City Manager Submitted by: Timothy Burroughs, Director, Planning and Development Department Subject: Cannabis Ordinance Revisions; Amending Berkeley Municipal Code Chapters 12.21, 12.22, 20.40, 23C.25, and Sub-Titles 23E and 23F RECOMMENDATION Conduct a public hearing and upon conclusion, provide direction regarding proposed ordinance language alternatives and take the following action: Adopt the first reading of five ordinances to amend the Berkeley Municipal Code (BMC) Chapters 12.21, 12.22, 20.40, 23C.25, and Sub-Titles 23E and 23F which would: A. Allow new business types (Delivery-Only Retailers, Consumption Lounges); B. Allow Retailers to continue to operate as Microbusinesses; C. Clarify cannabis business operational standards and development standards, such as quotas and buffers, for Storefront Retailers; D. Allow more opportunities for Commercial Cultivation by expanding location options; and E. Protect the health of the general public and youth with additional advertising, signage and sales regulations. SUMMARY The proposed cannabis ordinances would revise definitions and establish operating standards for new and existing cannabis businesses in Berkeley, and include new regulations based on commission recommendations, Council direction, and Resolution 68,326-N.S., which established Berkeley as a sanctuary city for recreational cannabis use. The new ordinances would fully address new uses (Delivery-Only Retailers, Consumption Lounges and Retail Storefront Microbusinesses1), and modify development standards and signage requirements for existing uses. The proposed ordinances were reviewed by the Cannabis Commission (CC) and the Community Health Commission (CHC).
    [Show full text]
  • Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender
    Opioid and Nicotine: Influences of Sex and Gender Conference Report: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender Authors: Bridget M. Nugent, PhD. Staff Fellow, FDA OWH Emily Ayuso, MS. ORISE Fellow, FDA OWH Rebekah Zinn, PhD. Health Program Coordinator, FDA OWH Erin South, PharmD. Pharmacist, FDA OWH Cora Lee Wetherington, PhD. Women & Sex/Gender Differences Research Coordinator, NIH NIDA Sherry McKee, PhD. Professor, Psychiatry; Director, Yale Behavioral Pharmacology Laboratory Jill Becker, PhD. Biopsychology Area Chair, Patricia Y. Gurin Collegiate Professor of Psychology and Research Professor, Molecular and Behavioral Neuroscience Institute, University of Michigan Hendrée E. Jones, Professor, Department of Obstetrics and Gynecology; Executive Director, Horizons, University of North Carolina at Chapel Hill Marjorie Jenkins, MD, MEdHP, FACP. Director, Medical Initiatives and Scientific Engagement, FDA OWH Acknowledgements: We would like to acknowledge and extend our gratitude to the meeting’s speakers and panel moderators: Mitra Ahadpour, Kelly Barth, Jill Becker, Kathleen Brady, Tony Campbell, Marilyn Carroll, Janine Clayton, Wilson Compton, Terri Cornelison, Teresa Franklin, Maciej Goniewcz, Shelly Greenfield, Gioia Guerrieri, Scott Gottlieb, Marsha Henderson, RADM Denise Hinton, Marjorie Jenkins, Hendrée Jones, Brian King, George Koob, Christine Lee, Sherry McKee, Tamra Meyer, Jeffery Mogil, Ann Murphy, Christine Nguyen, Cheryl Oncken, Kenneth Perkins, Yvonne Prutzman, Mehmet Sofuoglu, Jack Stein, Michelle Tarver, Martin Teicher, Mishka Terplan, RADM Sylvia Trent-Adams, Rita Valentino, Brenna VanFrank, Nora Volkow, Cora Lee Wetherington, Scott Winiecki, Mitch Zeller. We would also like to thank those who helped us plan this program. Our Executive Steering Committee included Ami Bahde, Carolyn Dresler, Celia Winchell, Cora Lee Wetherington, Jessica Tytel, Marjorie Jenkins, Pamela Scott, Rita Valentino, Tamra Meyer, and Terri Cornelison.
    [Show full text]